Efficacy and safety of combination therapies vs monotherapy of hypomethylating agents in accelerated or blast phase of Philadelphia negative myeloproliferative neoplasms: a systematic review and meta-analysis
AbstractBackground There is a lack of evidence regarding whether combination therapy of hypomethylating agents (HMAs) has better outcomes than HMA monotherapy in patients with Philadelphia chromosome-negative accelerated or blast phase myeloproliferative neoplasms (MPN-AP/BP).Materials and methods P...
| Những tác giả chính: | , , , |
|---|---|
| Định dạng: | Bài viết |
| Ngôn ngữ: | English |
| Được phát hành: |
Taylor & Francis Group
2023-12-01
|
| Loạt: | Annals of Medicine |
| Những chủ đề: | |
| Truy cập trực tuyến: | https://www.tandfonline.com/doi/10.1080/07853890.2022.2164611 |